HOTH News and Press, Hoth Therapeutics Inc. From 04/06/21

Hoth Therapeutics Engages Worldwide Clinical Trials as Contract Research Organization for Phase 2a HT-001 Clinical Trial for Cancer Patients PR Newswire NEW YORK , April 6, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biop...

Nano-X Imaging (NNOX) +68% as FDA OKs 510(k) for Single Source Nanox.ARC Digital X-Ray.Chembio Diagnostics (CEMI) +48%.NanoVibronix (NAOV) +24%.Leaf Group Ltd. (LEAF) +19% on being acquired by Graham Holdings for $8.50 per share.dMY Technology Group (DMYD) +19%.Hoth Therapeutics (HO...

Hoth Therapeutics (HOTH) announces that the Brazilian Patent Office has issued a notice of allowance for a patent application related to the company's method for inhibiting formation of biofilms.Biofilms are types of microorganisms that can grow on different surfaces.Shares up nearly 5%&...

Hoth Therapeutics, Inc. Announces Notice of Allowance for a New Patent Application Related to A Method for Inhibiting Formation of a Biofilm PR Newswire NEW YORK , April 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a patient-focused cli...

Gainers: Aptose Biosciences (APTO) +65%, Brainstorm Cell Therapeutics (BCLI) +13%, Prothena (PRTA) +12%, Armata Pharmaceuticals (ARMP) +8%, Inventiva (IVA) +8%.Losers: Benitec Biopharma (BNTC) -24%, Second Sight Medical Products (EYES) -1...

HaloVax, a vaccine candidate targeting COVID-19 has demonstrated positive data from its second set of preclinical animal testing, Voltron Therapeutics said.Developed in partnership with Hoth Therapeutics (HOTH), HaloVax is built on a base of a heat shock protein (HSP70)-Avidin fusion pro...

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing of its HaloVax™ Self-Assembling Vaccine (SAV) against COVID-19. This study investigated an updated construct, based on initial t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Hoth Therapeutics (NASDAQ: HOTH ) stock are skyrocketing on Tuesday following positive preclinical results from the firm’s novel coronavirus treatment. Source: Shutterstock Hoth said that ...

Gainers: Benitec Biopharma (BNTC) +71%, Hoth Therapeutics (HOTH) +26%, Aerpio Pharmaceuticals (ARPO) +12%, Soliton (SOLY) +11%, China Jo-Jo Drugstores (CJJD) +9%.Losers: Frequency Therapeutics (FREQ) -75%, Windtree Therapeutics (WINT) ...

Hoth Therapeutics (HOTH) soars 56% premarket after announcing new in vitro data demonstrating SARS-CoV-2 antiviral activity for its lead peptide candidate for HT-002, a novel therapeutic targeted for the treatment of COVID-19. The lead HT-002 peptide candidate was shown to inhi...